The microbiome of kidney stones and urine of patients with nephrolithiasis

The incidence of nephrolithiasis is rising worldwide.

Although it is a multifactorial disease, lifestyle plays a major role in its etiology.

Another considerable factor could be an aberrant microbiome.

In our observational single-center study, we aimed to investigate the composition of bacteria in kidney stones and urine focusing on patients with features of metabolic syndrome.

Catheterized urine and kidney stones were collected prospectively from 100 consecutive patients undergoing endoscopic nephrolithotomy between 2020 and 2021 at our clinic.

Microbiome composition was analyzed via 16S rRNA gene amplicon sequencing.

Detection of bacteria was successful in 24% of the analyzed kidney stones.

These patients had a prolonged length of stay compared to patients without verifiable bacteria in their stones (2.9 vs 1.5 days).

Patients with features of metabolic syndrome were characterized by kidney stones colonized with classical gastrointestinal bacteria and displayed a significant enrichment of Enterococcaceae and Enterobacteriaceae.

Stones of patients without features of metabolic syndrome characterized by Ureaplasma and Staphylococcaceae .

Patients with bacteria in their kidney stones exhibit a longer length of stay, possibly due to more complex care.

Patients presenting with features of metabolic syndrome displayed a distinct stone microbiome compared to metabolically fit patients.

Understanding the role of bacteria in stone formation could enable targeted therapy, prevention of post-operative complications and new therapeutic strategies.